UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?

Thrombosis and haemostasis, 2013, Vol.109 (5), p.956

2013

Link zum Volltext

Verfügbarkeit prüfen

Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients

Thrombosis and haemostasis, 2017, Vol.117 (7), p.1448

2017

Link zum Volltext

Verfügbarkeit prüfen

Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation

Thrombosis and haemostasis, 2013-12, Vol.110 (6), p.1189

2013

Link zum Volltext

Verfügbarkeit prüfen

Long‐Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC‐Stroke and CHA2DS2‐VASc Scores

Journal of the American Heart Association, 2017-07, Vol.6 (7), p.n/a

2017

Link zum Volltext

Verfügbarkeit prüfen

Is the ORBIT Bleeding Risk Score Superior to the HAS-BLED Score in Anticoagulated Atrial Fibrillation Patients?

Circulation Journal, 2016/09/23, Vol.80(10), pp.2102-2108

2016

Link zum Volltext

Verfügbarkeit prüfen

Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores. The Murcia Atrial Fibrillation Project

Thrombosis and haemostasis, 2017-10, Vol.117 (10), p.1848

2017

Link zum Volltext

Verfügbarkeit prüfen

A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the “Real-World” vs Clinical Trials

Mayo Clinic proceedings, 2018-08, Vol.93 (8), p.1065-1073

2018

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Predictors of Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion

Circulation Journal, 2016/02/25, Vol.80(3), pp.605-612

2016

Link zum Volltext

Verfügbarkeit prüfen

Relation of the HAS-BLED Bleeding Risk Score to Major Bleeding, Cardiovascular Events, and Mortality in Anticoagulated Patients With Atrial Fibrillation

Circulation. Arrhythmia and electrophysiology, 2012-04, Vol.5 (2), p.312-318

2012

Link zum Volltext

Verfügbarkeit prüfen

Atherosclerosis and thromboembolic risk in atrial fibrillation: Focus on peripheral vascular disease

Annals of medicine (Helsinki), 2013-05, Vol.45 (3), p.274-290

2013

Link zum Volltext

Verfügbarkeit prüfen

Ankle brachial index as an independent predictor of mortality in anticoagulated atrial fibrillation

European journal of clinical investigation, 2012-12, Vol.42 (12), p.1302-1308

2012

Link zum Volltext

Verfügbarkeit prüfen

Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol

Clinical therapeutics, 2018-01, Vol.40 (1), p.114-122

2018

Link zum Volltext

Verfügbarkeit prüfen

Usefulness of N-Terminal Pro-B-Type Natriuretic Peptide Levels for Stroke Risk Prediction in Anticoagulated Patients With Atrial Fibrillation

Stroke (1970), 2014-03, Vol.45 (3), p.696-701

2014

Link zum Volltext

Verfügbarkeit prüfen

Should We Recommend Oral Anticoagulation Therapy in Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting With a High HAS-BLED Bleeding Risk Score?

Circulation. Cardiovascular interventions, 2012-08, Vol.5 (4), p.459-466

2012

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation

European journal of clinical investigation, 2018-06, Vol.48 (6), p.e12929-n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

sST2 levels are associated with all-cause mortality in anticoagulated patients with atrial fibrillation

European journal of clinical investigation, 2015-09, Vol.45 (9), p.899-905

2015

Link zum Volltext

Verfügbarkeit prüfen

The SAMe-TT2R2 score and decision-making between a vitamin K antagonist or a non-vitamin K antagonist oral anticoagulant in patients with atrial fibrillation

Expert review of cardiovascular therapy, 2016-01, Vol.14 (2), p.177-187

2016

Link zum Volltext

Verfügbarkeit prüfen

The prognostic role of the adiponectin levels in atrial fibrillation

European journal of clinical investigation, 2013-02, Vol.43 (2), p.168-173

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation

European heart journal, 2009-04, Vol.30 (8), p.932-939

2009

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Estimated Glomerular Filtration Rate Equations for Dosing New Oral Anticoagulants in Patients With Atrial Fibrillation

Revista española de cardiología (English ed.), 2015-06, Vol.68 (6), p.497-504

2015

Link zum Volltext

Verfügbarkeit prüfen

Escalas de evaluación del riesgo tromboembólico y hemorrágico en la fibrilación auricular

Revista Española de Cardiología (Suplementos), 2016, Vol.16, p.25-32

2016

Link zum Volltext

Verfügbarkeit prüfen

Comparación de las ecuaciones de filtrado glomerular estimado para determinar la posología de los nuevos anticoagulantes orales para pacientes con fibrilación auricular

Revista española de cardiologia, 2015-06, Vol.68 (6), p.497-504

2015

Link zum Volltext

Verfügbarkeit prüfen

Repercusiones en la posología de los anticoagulantes orales no antagonistas de la vitamina K por las variaciones de la función renal de los pacientes con fibrilación auricular e insuficiencia cardiaca aguda reciente

Revista española de cardiologia, 2016-02, Vol.69 (2), p.134-140

2016

Link zum Volltext

Verfügbarkeit prüfen

Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk

Annals of medicine (Helsinki), 2010-12, Vol.42 (8), p.562-575

2010

Link zum Volltext

Verfügbarkeit prüfen

Valor predictivo de la escala CHA2DS2-VASc en pacientes con fibrilación auricular de alto riesgo embólico en tratamiento anticoagulante

Revista española de cardiologia, 2012-07, Vol.65 (7), p.627-633

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

KollektionEbook Central Perpetual and DDA

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

Nur zeigenMit Volltextzugriff

ThemaInternal Medicine

ThemaAtrial Fibrillation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)

Publikationsform

Artikel
(29)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Humans
(20)
Female
(17)
Male
(17)
Risk Factors
(17)
Aged
(16)
Cardiovascular System & Cardiology
(12)
Aged, 80 And Over
(11)
Atrial Fibrillation - Complications
(10)
Atrial Fibrillation - Drug Therapy
(10)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Anticoagulants - Adverse Effects
(9)
Mortality
(9)
Anticoagulants
(8)
Anticoagulants - Therapeutic Use
(8)
Atrial Fibrillation - Mortality
(8)
Cardiac & Cardiovascular Systems
(8)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?

Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients

Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation

Long‐Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC‐Stroke and CHA2DS2‐VASc Scores

Is the ORBIT Bleeding Risk Score Superior to the HAS-BLED Score in Anticoagulated Atrial Fibrillation Patients?

Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores. The Murcia Atrial Fibrillation Project

A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the “Real-World” vs Clinical Trials

Long-Term Predictors of Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion

Relation of the HAS-BLED Bleeding Risk Score to Major Bleeding, Cardiovascular Events, and Mortality in Anticoagulated Patients With Atrial Fibrillation

Atherosclerosis and thromboembolic risk in atrial fibrillation: Focus on peripheral vascular disease

Ankle brachial index as an independent predictor of mortality in anticoagulated atrial fibrillation

Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol

Usefulness of N-Terminal Pro-B-Type Natriuretic Peptide Levels for Stroke Risk Prediction in Anticoagulated Patients With Atrial Fibrillation

Should We Recommend Oral Anticoagulation Therapy in Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting With a High HAS-BLED Bleeding Risk Score?

Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation

sST2 levels are associated with all-cause mortality in anticoagulated patients with atrial fibrillation

The SAMe-TT2R2 score and decision-making between a vitamin K antagonist or a non-vitamin K antagonist oral anticoagulant in patients with atrial fibrillation

The prognostic role of the adiponectin levels in atrial fibrillation

Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation

Comparison of Estimated Glomerular Filtration Rate Equations for Dosing New Oral Anticoagulants in Patients With Atrial Fibrillation

Escalas de evaluación del riesgo tromboembólico y hemorrágico en la fibrilación auricular

Comparación de las ecuaciones de filtrado glomerular estimado para determinar la posología de los nuevos anticoagulantes orales para pacientes con fibrilación auricular

Repercusiones en la posología de los anticoagulantes orales no antagonistas de la vitamina K por las variaciones de la función renal de los pacientes con fibrilación auricular e insuficiencia cardiaca aguda reciente

Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk

Valor predictivo de la escala CHA2DS2-VASc en pacientes con fibrilación auricular de alto riesgo embólico en tratamiento anticoagulante

Aktive Filter

Suchergebnisse filtern